Structural biology and drug discovery
5 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- WEIZMANN INSTITUTE OF SCIENCE
World-class Israeli research institute excelling in neuroscience, cancer biology, immunotherapy, and genomics through ERC-funded investigator-driven science.
“Participation in NMR/EM/X-ray infrastructure (iNEXT), bioinformatics platforms (ELIXIR-EXCELERATE), and chemical biology projects.”
IL214 projects - JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN
Major German research university specializing in vascular RNA biology, neuroscience, structural biology, and biomarker-driven drug discovery.
“Participated in iNEXT (NMR/EM/X-ray infrastructure for translational research) and multiple projects involving biomarkers, omics, and drug development pipelines.”
PrimaryDE110 projects - ETHNIKO IDRYMA EREVNON
Greece's national research foundation serving as NCP hub across H2020 pillars, with active research in structural biology and open science infrastructure.
“Coordinated EuroNeurotrophin (training network for neurotrophin mimetics as drug candidates) and participated in INSTRUCT-ULTRA for integrated structural biology access.”
EL37 projects - EOTVOS LORAND TUDOMANYEGYETEM
Hungary's leading research university, strong in theoretical physics, structural biology, evolutionary science, and increasingly in health and AI governance.
“Consistent participation across iNEXT, iNEXT-Discovery, MAGICBULLET, Magicbullet Reloaded, and IDPfun — spanning protein structure, NMR, and targeted drug delivery.”
PrimaryHU35 projects - ELETTRA - SINCROTRONE TRIESTE SCPA
Italian synchrotron light source facility providing X-ray imaging, spectroscopy, and structural biology services across 24 H2020 research infrastructure projects.
“EXSCALATE4CoV (crystallography and cryo-EM for COVID drug screening), AntiHelix (DNA helicase mechanisms), and structural biology training via OPEN SESAME”
IT24 projects